Who invested in Embolx?
Embolx's investors include National Science Foundation, National Institutes of Health and MedTech Innovator.
Who invested in Embolx
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2019, from 1 source
- Latest round
- VentureJun 2019
- Investors
- 3
The rounds
- Jun 2019VentureAmount undisclosed
Source recorded
Founders and team
From Embolx's own website and the SEC filings it signed: 8 on the team.
- Michael AllenPresident & Chief Executive Officer
- Matthew NalipinskiVP of Operations and Engineering
- Robert HornakDirector of Sales
- Michael LinDirector of Financei
- Norman GitisChairman
- Paul RoganBoard Member
- Tianhong XuBoard Member
- Tom BretonManager of Research & Developmenti
On the board, as filediFrank Grillo
AdvisersRick Stark
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Embolx
How much has Embolx raised?
Embolx has raised 1 round since 2019, none with a disclosed amount.
When did Embolx last raise?
Embolx's most recent round was a Venture in Jun 2019.
Who backed Embolx first?
Embolx's first round on record, in Jun 2019, was backed by National Science Foundation, National Institutes of Health and MedTech Innovator.
What stage is Embolx at?
Embolx's latest named round is a Venture, in Jun 2019.
Companies like Embolx
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.